DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prohance (Gadoteridol) - Published Studies


Prohance Related Published Studies

Well-designed clinical trials related to Prohance (Gadoteridol)

Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases. [2011.07]

Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases. [2011]

Well-designed clinical trials possibly related to Prohance (Gadoteridol)

Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI. [2006.07]

Other research related to Prohance (Gadoteridol)

Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis. [2008.05]

Other possibly related research studies

Indirect MR lymphangiography of the head and neck using conventional gadolinium contrast: a pilot study in humans. [2006.10.01]

The effect of MR contrast medium dose on pituitary gland enhancement, microlesion enhancement and pituitary gland-to-lesion contrast conspicuity. [2006.07]

Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. [2005.12]

A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent. [2005.06]

Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents. [2005.07]

Stenosis detection with MR angiography and digital subtraction angiography in dysfunctional hemodialysis access fistulas and grafts. [2005.01]

Real-time imaging and quantification of brain delivery of liposomes. [2006.11]

Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. [2006.06]

Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. [2005.12]

MR arthrography of the glenohumeral joint: modified posterior approach without imaging guidance. [2007.02]

Contrast-enhanced hepatic magnetic resonance angiography at 3 T: does parallel imaging improve image quality? [2007.03]

A simple catheter-vessel model for MR assessment of drug distribution in arteries and optimization of catheter design for intraarterial infusion therapy. [2007.05]

Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. [2007.07]

Staining methods for magnetic resonance microscopy of the rat fetus. [2007.06]

Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis. [2007.09]

Contrast enhanced cartilage imaging: Comparison of ionic and non-ionic contrast agents. [2007.07]

Measurement of serum calcium concentration after administration of four gadolinium-based contrast agents to human volunteers. [2007.12]

Difference in enhancement between spin echo and 3-dimensional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging. [2008.03]

Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. [2008.04]

The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging. [2008.01]

What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard? [2008.04]

Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery. [2008.11]

Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results. [2008.11]

MR lymphangiography for the assessment of the lymphatic system in patients undergoing microsurgical reconstructions of lymphatic vessels. [2008.05]

Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast. [2009.06]

MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema. [2009.05]

Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. [2009.02]

In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes. [2010.06.15]

Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. [2010.04.02]

Mechanism of NSF: New evidence challenging the prevailing theory. [2009.12]

Convection-enhanced delivery of liposomes to primate brain. [2009]

MR imaging of endometrial carcinoma for preoperative staging at 3.0 T: comparison with imaging at 1.5 T. [2009.09]

Anatomic compression caused by high-volume convection-enhanced delivery to the brain. [2009.09]

MR evaluation of retroperitoneal fibrosis. [2011.08]

Evaluation of the glenoid labrum with 3-T MRI: is intraarticular contrast necessary? [2011.05]

Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. [2011.03.04]

Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. [2011.06]

Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. [2011]

Incidence of immediate gadolinium contrast media reactions. [2011.02]

Endolymphatic hydrops and blood-labyrinth barrier in Meniere's disease. [2011.05]

Estimation of gadolinium-induced T1-shortening with measurement of simple signal intensity ratio between the cochlea and brain parenchyma on 3D-FLAIR: correlation with T1 measurement by TI scout sequence. [2010]

Design of an in-dwelling cannula for convection-enhanced delivery. [2011.03.15]

Imaging patients with kidney disease: how do we approach contrast-related toxicity? [2011.03]

Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy. [2010.11]

Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. [2011.02.28]

Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent. [2010.09]

Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients. [2010.10]

Canine spontaneous glioma: a translational model system for convection-enhanced delivery. [2010.09]

Image-guided convection-enhanced delivery of GDNF protein into monkey putamen. [2011.01]

Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. [2011.01]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017